Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 104695501000001114 | Pibrentasvir (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 104695601000001113 | Pibrentasvir | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pibrentasvir | Is a | Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glecaprevir 100mg / Pibrentasvir 40mg tablets | Has specific active ingredient | False | Pibrentasvir | Inferred relationship | Existential restriction modifier | |
| Maviret 100mg/40mg tablets (AbbVie Ltd) | Has specific active ingredient | False | Pibrentasvir | Inferred relationship | Existential restriction modifier | |
| Glecaprevir 100mg / Pibrentasvir 40mg tablets 84 tablet | Has specific active ingredient | False | Pibrentasvir | Inferred relationship | Existential restriction modifier | |
| Maviret 100mg/40mg tablets (AbbVie Ltd) 84 tablet 4 x 21 tablets | Has specific active ingredient | False | Pibrentasvir | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR